Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as ...

In a letter, three Maryland Democrats said they had "grave concerns" that Trump's move would do lasting damage ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to ...

The rapidity with which the new administration is putting in place policies to end DEI programs is sowing fear among ...

A trio of Democrats on Monday called on the Trump administration to restore full operations at the National Institutes of ...

Just days after President Trump imposed broad restrictions on communications, meetings, travel and public appearances at the ...

The University of Nebraska said it was waiting for more information about what a pause in activities at the National ...

The agency expects “additional guidance” this week on the communications freeze — which unleashed confusion about whether ...

Oregon in 2023 raked in $428 million in grants from NIH, a little less than the peak of $436 million in 2020. The agency's ...

New rules include a hold on the review panels the National Institutes of Health uses to evaluate and approve research grants.

The abrupt pause in hiring, public communications, meetings and training workshops for some scientists at the Maryland-based ...

Researchers at the National Institutes of Health say the move has sent fear and confusion throughout the agency.